XML 26 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net income $ 31,951 $ 12,609
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 92,137 80,793
Equity in income of joint ventures (7,101) (8,714)
Stock-based compensation expense 14,282 12,420
Elimination of unrealized loss on sales to joint ventures 0 (315)
Changes in fair value of contingent consideration 0 (6,172)
Deferred taxes (16,049) (618)
Unrealized foreign exchange (gain) loss (6,047) 5,413
Changes in assets and liabilities:    
Accounts receivable, net 15,118 (33,756)
Inventories (9,020) (7,521)
Other assets (11,557) (14,127)
Accounts payable and accrued liabilities (17,289) (11,129)
Other liabilities 12,931 (12,805)
Income taxes, net (6,599) 3,432
Dividends received from joint ventures 498 0
Other (3,333) (2,745)
Net cash provided by operating activities 89,922 16,765
Cash flows from investing activities:    
Capital expenditures (54,316) (67,107)
Payment for acquisition of business, net of cash acquired 0 (32,458)
Proceeds from disposal of assets 5,000 2,900
Net cash used in investing activities (49,316) (96,665)
Cash flows from financing activities:    
(Cash pledged for) release of collateral deposits, net (415) 557
Proceeds from borrowings 0 117,269
Repayment of borrowings 0 (44,351)
Repurchase of common stock (15,033) 0
Payment of withholding taxes on stock-based compensation plans (2,588) (4,352)
Repayment of financed insurance premium (4,955) (3,203)
Repayments of finance leases (887) (1,042)
Net cash (used in) provided by financing activities (23,878) 64,878
Effect of exchange rate changes on cash and cash equivalents 6,095 (2,691)
Net increase (decrease) to cash and cash equivalents and restricted cash 22,823 (17,713)
Cash and cash equivalents and restricted cash at beginning of period 184,663 153,166
Cash and cash equivalents and restricted cash at end of period $ 207,486 $ 135,453